VITREX MEDICAL A/S: Financial statements 2023
CVR: 14728732
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 28,138,595 and a net result of DKK 1,214,691 compared with DKK 4,052,982 the year before. That is an increase of 5.9% compared with the year before. Equity in the 2023 report amounted to DKK 34,248,035. The solvency ratio was 57%. The company had 68 employees in the financial year.
- Gross Profit
- DKK 28,138,595
- Profit/Loss
- DKK 1,214,691
- Equity
- DKK 34,248,035
- Total Assets
- DKK 60,113,581
- Employees
- 68
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 28.1M | 1.2M | 34.2M | 68 |
| 2022 | - | 26.6M | 4.1M | 33M | 73 |
| 2021 | - | 28.6M | 5.5M | 32M | 68 |
| 2020 | - | 25.9M | 7.6M | 31.5M | 64 |
| 2019 | - | 21.6M | 4.1M | 24.9M | 60 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 1, 2023, Marcin Sieczek has joined the board of directors of VITREX MEDICAL A/S.
As of December 1, 2023, Teodor Lysák has left the board of directors of VITREX MEDICAL A/S.
VITREX MEDICAL A/S has published its annual report for 2022. Gross profit came to DKK 26,582,922, and the net result was DKK 4,052,982.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.
